Examining Recent Advances in Understanding and Treatment of Dry Eye Disease: An Eye on the Pharmacist's Role
This Continuing Education activity is supported by an educational grant from Alcon, Inc.
This activity is supported by an educational grant from Alcon, Inc.
Faculty
Clark Kebodeaux, PharmD, BCACP
Assistant Professor of Pharmacy Practice
St. Louis College of Pharmacy
St. Louis, Missouri
Shared Faculty, Walgreens Pharmacy
Jamie Shelly, PharmD
Assistant Professor of Pharmacy Practice
St. Louis College of Pharmacy
St. Louis, Missouri
Wellness Pharmacist-Shared Faculty
Shop ‘n Save Pharmacies
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Examine the pathophysiology of dry eye disease (DED).
- Explain the diagnostic challenges of DED.
- Determine the causes of DED, as well as its clinical and quality of life impact.
- Illustrate nonpharmacologic and pharmacologic therapies based on the severity of DED.
- Analyze implications for the pharmacist in regard to providing patient education on risk factors, prevention, and management of DED.
Target audience: Pharmacists
Type of activity: Application
Release date: September 7, 2015
Expiration date: September 7, 2016
Estimated time to complete activity: 1.5 hours
Fee: Free
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-15-096-H01-P. The activity is available for CE credit through September 7, 2016.
